Novo Nordisk's Wegovy just lost patent protection in India, and low-cost generics have flooded onto the scene
faqs GLP-1 microdosing is the use of very low, personalized doses of GLP-1 receptor agonists to support appetite control, blood sugar balance, and fat loss while minimizing side effects commonly seen with standard dosing
It reiterates that clinicians should only prescribe the medicines for their licensed indication and proactively engage with and prioritise for review those patients who have been impacted by the shortages which have been happening since last summer
The FDA-approved use of this medication varies according to the brand names
Rare but serious side effects include pancreatitis (characterised by severe, persistent abdominal pain), hypoglycaemia (particularly when used with insulin or sulphonylureas, which may require dose reduction of these agents), and thyroid C-cell tumours (observed in animal studies, though the human relevance is unknown)
This brings the total to 16 brands that the agency has included in its public health alert about lead in cinnamon